Annual Net Income
-$3.08 M
+$894.00 K+22.50%
31 December 2023
Summary:
China Pharma Holdings annual net profit is currently -$3.08 million, with the most recent change of +$894.00 thousand (+22.50%) on 31 December 2023. During the last 3 years, it has fallen by -$212.00 thousand (-7.40%). CPHI annual net income is now -113.15% below its all-time high of $23.41 million, reached on 31 December 2010.CPHI Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$1.12 M
+$320.20 K+22.27%
30 September 2024
Summary:
China Pharma Holdings quarterly net profit is currently -$1.12 million, with the most recent change of +$320.20 thousand (+22.27%) on 30 September 2024. Over the past year, it has dropped by -$340.30 thousand (-43.76%). CPHI quarterly net income is now -115.61% below its all-time high of $7.16 million, reached on 30 September 2009.CPHI Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$4.74 M
-$340.30 K-7.73%
30 September 2024
Summary:
China Pharma Holdings TTM net profit is currently -$4.74 million, with the most recent change of -$340.30 thousand (-7.73%) on 30 September 2024. Over the past year, it has dropped by -$1.63 million (-52.50%). CPHI TTM net income is now -120.05% below its all-time high of $23.66 million, reached on 31 March 2011.CPHI TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPHI Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.5% | -43.8% | -52.5% |
| 3 y3 years | -7.4% | -35.2% | -30.8% |
| 5 y5 years | +71.4% | -59.5% | +50.3% |
CPHI Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -7.4% | +22.5% | -134.8% | +22.3% | -54.1% | at low |
| 5 y | 5 years | -7.4% | +85.1% | -8633.6% | +94.0% | -65.5% | +77.3% |
| alltime | all time | -113.2% | +92.2% | -115.6% | +95.0% | -120.0% | +88.5% |
China Pharma Holdings Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.12 M(-22.3%) | -$4.74 M(+7.7%) |
| June 2024 | - | -$1.44 M(+50.4%) | -$4.40 M(+23.7%) |
| Mar 2024 | - | -$955.90 K(-22.4%) | -$3.56 M(+15.6%) |
| Dec 2023 | -$3.08 M(-22.5%) | -$1.23 M(+58.5%) | -$3.08 M(-1.0%) |
| Sept 2023 | - | -$777.60 K(+31.1%) | -$3.11 M(-0.4%) |
| June 2023 | - | -$593.00 K(+24.6%) | -$3.12 M(-8.6%) |
| Mar 2023 | - | -$476.00 K(-62.3%) | -$3.42 M(-13.9%) |
| Dec 2022 | -$3.97 M(+16.9%) | -$1.26 M(+59.9%) | -$3.97 M(+7.7%) |
| Sept 2022 | - | -$790.80 K(-11.0%) | -$3.69 M(-1.0%) |
| June 2022 | - | -$888.40 K(-13.7%) | -$3.73 M(+1.7%) |
| Mar 2022 | - | -$1.03 M(+5.0%) | -$3.66 M(+7.7%) |
| Dec 2021 | -$3.40 M(+18.6%) | -$980.70 K(+18.6%) | -$3.40 M(-6.3%) |
| Sept 2021 | - | -$826.70 K(+0.2%) | -$3.63 M(-4.8%) |
| June 2021 | - | -$824.80 K(+7.5%) | -$3.81 M(+28.2%) |
| Mar 2021 | - | -$767.30 K(-36.5%) | -$2.97 M(+3.7%) |
| Dec 2020 | -$2.87 M(-86.2%) | -$1.21 M(+19.7%) | -$2.87 M(-85.9%) |
| Sept 2020 | - | -$1.01 M(-7809.2%) | -$20.40 M(+1.5%) |
| June 2020 | - | $13.10 K(-102.0%) | -$20.09 M(-4.1%) |
| Mar 2020 | - | -$660.90 K(-96.5%) | -$20.95 M(+1.2%) |
| Dec 2019 | -$20.70 M(+92.6%) | -$18.75 M(+2574.1%) | -$20.70 M(+116.8%) |
| Sept 2019 | - | -$701.00 K(-16.4%) | -$9.55 M(-10.8%) |
| June 2019 | - | -$838.10 K(+100.6%) | -$10.70 M(-1.6%) |
| Mar 2019 | - | -$417.70 K(-94.5%) | -$10.87 M(+1.2%) |
| Dec 2018 | -$10.75 M(-44.2%) | -$7.59 M(+308.9%) | -$10.75 M(-36.7%) |
| Sept 2018 | - | -$1.86 M(+84.2%) | -$16.99 M(-2.0%) |
| June 2018 | - | -$1.01 M(+243.4%) | -$17.32 M(-6.9%) |
| Mar 2018 | - | -$293.50 K(-97.9%) | -$18.60 M(-3.5%) |
| Dec 2017 | -$19.28 M(+109.9%) | -$13.83 M(+529.8%) | -$19.28 M(+117.2%) |
| Sept 2017 | - | -$2.20 M(-4.0%) | -$8.88 M(+5.3%) |
| June 2017 | - | -$2.29 M(+136.6%) | -$8.43 M(-1.9%) |
| Mar 2017 | - | -$966.90 K(-71.8%) | -$8.60 M(-6.4%) |
| Dec 2016 | -$9.18 M(-40.4%) | -$3.43 M(+95.8%) | -$9.18 M(-23.5%) |
| Sept 2016 | - | -$1.75 M(-28.7%) | -$12.00 M(+63.9%) |
| June 2016 | - | -$2.45 M(+58.0%) | -$7.32 M(+95.7%) |
| Mar 2016 | - | -$1.55 M(-75.1%) | -$3.74 M(-40.2%) |
| Dec 2015 | -$15.41 M(-61.0%) | -$6.25 M(-313.1%) | -$6.26 M(-71.8%) |
| Sept 2015 | - | $2.93 M(+160.1%) | -$22.20 M(-29.4%) |
| June 2015 | - | $1.13 M(-127.7%) | -$31.46 M(-23.7%) |
| Mar 2015 | - | -$4.07 M(-81.7%) | -$41.23 M(+4.2%) |
| Dec 2014 | -$39.55 M(+97.7%) | -$22.19 M(+250.7%) | -$39.55 M(+42.3%) |
| Sept 2014 | - | -$6.33 M(-26.8%) | -$27.79 M(+16.9%) |
| June 2014 | - | -$8.64 M(+261.6%) | -$23.77 M(+21.3%) |
| Mar 2014 | - | -$2.39 M(-77.1%) | -$19.59 M(-2.1%) |
| Dec 2013 | -$20.01 M(-533.3%) | -$10.43 M(+353.1%) | -$20.01 M(+84.9%) |
| Sept 2013 | - | -$2.30 M(-48.4%) | -$10.82 M(+49.8%) |
| June 2013 | - | -$4.46 M(+58.7%) | -$7.22 M(+621.7%) |
| Mar 2013 | - | -$2.81 M(+126.1%) | -$1.00 M(-121.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | $4.62 M(-76.0%) | -$1.24 M(-196.0%) | $4.62 M(-53.7%) |
| Sept 2012 | - | $1.30 M(-26.4%) | $9.98 M(-26.9%) |
| June 2012 | - | $1.76 M(-37.3%) | $13.66 M(-19.5%) |
| Mar 2012 | - | $2.81 M(-31.9%) | $16.97 M(-11.9%) |
| Dec 2011 | $19.27 M(-17.7%) | $4.12 M(-17.1%) | $19.27 M(-11.2%) |
| Sept 2011 | - | $4.97 M(-1.9%) | $21.71 M(-4.1%) |
| June 2011 | - | $5.07 M(-0.7%) | $22.65 M(-4.3%) |
| Mar 2011 | - | $5.10 M(-22.2%) | $23.66 M(+1.1%) |
| Dec 2010 | $23.41 M(+30.3%) | $6.56 M(+11.0%) | $23.41 M(+18.9%) |
| Sept 2010 | - | $5.91 M(-2.8%) | $19.70 M(-6.0%) |
| June 2010 | - | $6.08 M(+25.3%) | $20.95 M(+9.4%) |
| Mar 2010 | - | $4.85 M(+70.5%) | $19.15 M(+6.5%) |
| Dec 2009 | $17.97 M(+0.8%) | $2.85 M(-60.3%) | $17.97 M(-12.2%) |
| Sept 2009 | - | $7.16 M(+67.1%) | $20.48 M(+16.6%) |
| June 2009 | - | $4.29 M(+16.5%) | $17.57 M(+1.4%) |
| Mar 2009 | - | $3.68 M(-31.3%) | $17.32 M(-2.9%) |
| Dec 2008 | $17.83 M(+39.1%) | $5.35 M(+25.9%) | $17.83 M(+8.0%) |
| Sept 2008 | - | $4.25 M(+5.3%) | $16.51 M(+7.6%) |
| June 2008 | - | $4.04 M(-3.7%) | $15.35 M(+4.9%) |
| Mar 2008 | - | $4.19 M(+3.9%) | $14.64 M(+14.2%) |
| Dec 2007 | $12.82 M(+49.3%) | $4.03 M(+30.8%) | $12.82 M(+4.5%) |
| Sept 2007 | - | $3.08 M(-7.3%) | $12.26 M(+12.7%) |
| June 2007 | - | $3.33 M(+40.1%) | $10.89 M(+15.9%) |
| Mar 2007 | - | $2.37 M(-31.8%) | $9.39 M(+8.7%) |
| Dec 2006 | $8.59 M(+126.0%) | $3.48 M(+103.8%) | $8.63 M(+67.5%) |
| Sept 2006 | - | $1.71 M(-6.8%) | $5.16 M(+30.2%) |
| June 2006 | - | $1.83 M(+13.1%) | $3.96 M(+1029.1%) |
| Mar 2006 | - | $1.62 M(+217.2%) | $350.70 K(-126.5%) |
| Dec 2005 | $3.80 M(-306.2%) | - | - |
| Sept 2005 | - | $510.40 K(-128.7%) | -$1.32 M(-28.3%) |
| June 2005 | - | -$1.78 M(+4882.1%) | -$1.84 M(+1793.5%) |
| June 2005 | -$1.84 M(+265.3%) | - | - |
| Mar 2005 | - | -$35.70 K(+105.2%) | -$97.30 K(+67.5%) |
| Dec 2004 | - | -$17.40 K(+62.6%) | -$58.10 K(+40.7%) |
| Sept 2004 | - | -$10.70 K(-68.1%) | -$41.30 K(-91.8%) |
| June 2004 | -$504.30 K(-3.3%) | -$33.50 K(-1057.1%) | -$504.40 K(-37.5%) |
| Mar 2004 | - | $3500.00(-683.3%) | -$806.60 K(-9.5%) |
| Dec 2003 | - | -$600.00(-99.9%) | -$891.70 K(-10.4%) |
| Sept 2003 | - | -$473.80 K(+41.1%) | -$994.70 K(+91.1%) |
| June 2003 | -$521.40 K(-52.8%) | -$335.70 K(+311.4%) | -$520.60 K(-21.0%) |
| Mar 2003 | - | -$81.60 K(-21.2%) | -$659.30 K(-29.6%) |
| Dec 2002 | - | -$103.60 K(<-9900.0%) | -$937.10 K(+0.5%) |
| Sept 2002 | - | $300.00(-100.1%) | -$932.90 K(-15.5%) |
| June 2002 | -$1.10 M | -$474.40 K(+32.0%) | -$1.10 M(+75.3%) |
| Mar 2002 | - | -$359.40 K(+261.6%) | -$629.70 K(+133.0%) |
| Dec 2001 | - | -$99.40 K(-41.8%) | -$270.30 K(+58.2%) |
| Sept 2001 | - | -$170.90 K | -$170.90 K |
FAQ
- What is China Pharma Holdings annual net profit?
- What is the all time high annual net income for China Pharma Holdings?
- What is China Pharma Holdings annual net income year-on-year change?
- What is China Pharma Holdings quarterly net profit?
- What is the all time high quarterly net income for China Pharma Holdings?
- What is China Pharma Holdings quarterly net income year-on-year change?
- What is China Pharma Holdings TTM net profit?
- What is the all time high TTM net income for China Pharma Holdings?
- What is China Pharma Holdings TTM net income year-on-year change?
What is China Pharma Holdings annual net profit?
The current annual net income of CPHI is -$3.08 M
What is the all time high annual net income for China Pharma Holdings?
China Pharma Holdings all-time high annual net profit is $23.41 M
What is China Pharma Holdings annual net income year-on-year change?
Over the past year, CPHI annual net profit has changed by +$894.00 K (+22.50%)
What is China Pharma Holdings quarterly net profit?
The current quarterly net income of CPHI is -$1.12 M
What is the all time high quarterly net income for China Pharma Holdings?
China Pharma Holdings all-time high quarterly net profit is $7.16 M
What is China Pharma Holdings quarterly net income year-on-year change?
Over the past year, CPHI quarterly net profit has changed by -$340.30 K (-43.76%)
What is China Pharma Holdings TTM net profit?
The current TTM net income of CPHI is -$4.74 M
What is the all time high TTM net income for China Pharma Holdings?
China Pharma Holdings all-time high TTM net profit is $23.66 M
What is China Pharma Holdings TTM net income year-on-year change?
Over the past year, CPHI TTM net profit has changed by -$1.63 M (-52.50%)